ArticleOncotarget2015

Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.

Yi-Hua Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.